Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163317 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02163317 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 12 participants.
The verdict
NCT02163317, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This pilot clinical trial studies magnetic resonance (MRI)-guided focal stereotactic radiosurgery (SRS) in treating patients with low- or intermediate-risk localized prostate cancer. Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
Interventions
- OTHER quality-of-life assessment
- RADIATION stereotactic radiosurgery
- DEVICE magnetic resonance imaging
- PROCEDURE Serum Prostate Antigen Test
- PROCEDURE Digital Rectal Exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-02-16 |
| Est. Completion | 2021-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02163317
The ClinicalTrials.gov registry entry for NCT02163317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which quality-of-life assessment is the first listed.
NCT02163317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02163317 about?
NCT02163317 is a clinical study titled "Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer". This pilot clinical trial studies magnetic resonance (MRI)-guided focal stereotactic radiosurgery (SRS) in treating patients with low- or intermediate-risk localized prostate cancer. Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
What is the current status of trial NCT02163317?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-02-16. Estimated completion is 2021-07-28.
What interventions are being tested in trial NCT02163317?
The interventions under investigation include: quality-of-life assessment (OTHER), stereotactic radiosurgery (RADIATION), magnetic resonance imaging (DEVICE), Serum Prostate Antigen Test (PROCEDURE), Digital Rectal Exam (PROCEDURE).
Who is sponsoring clinical trial NCT02163317?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.